Fig. 4: Survival analysis in immune checkpoint inhibitors (ICI)-naïve patients with TNBC. | Communications Medicine

Fig. 4: Survival analysis in immune checkpoint inhibitors (ICI)-naïve patients with TNBC.

From: Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer

Fig. 4: Survival analysis in immune checkpoint inhibitors (ICI)-naïve patients with TNBC.The alternative text for this image may have been generated using AI.

Kaplan-Meier curves displaying the (a) Disease-Free Survival (DFS) and (b) Overall Survival (OS) of ICI-naïve patients with TNBC, stratified using TNBC-ICI. The classifier does not predict increased survival in ICI-naïve patients with TNBC.

Back to article page